Skip to main content
Kathrin Bernt, MD, Pediatric Hematology & Oncology, Philadelphia, PA, Children's Hospital of Philadelphia

KathrinMariaBerntMD

Pediatric Hematology & Oncology • Philadelphia, PA

Instructor in Pediatrics, Dana-Farber Cancer Institute

Join to view full profile

Dr. Bernt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bernt's full profile

Already have an account?

Education & Training

  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2006 - 2009
  • University of Washington
    University of WashingtonResidency, Pediatrics, 2003 - 2006
  • Humboldt University of Berlin - Charite Faculty of Medicine
    Humboldt University of Berlin - Charite Faculty of MedicineClass of 1998

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2017 - 2024
  • CO State Medical License
    CO State Medical License 2013 - 2017
  • MA State Medical License
    MA State Medical License 2009 - 2012
  • WA State Medical License
    WA State Medical License 2003 - 2004
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • SWI/SNF Dysregulation through a Prion-like Domain Causes AMLClinically Relevant Abstract
    Kathrin M. Bernt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Chromatin Structure in Development and Disease 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Continuing Conversations With the Speakers on Chromatin Structure in Development and Disease 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Study May Widen Patient Pool That Benefits from EPZ-5676 Against Acute Myeloid Leukemia
    Study May Widen Patient Pool That Benefits from EPZ-5676 Against Acute Myeloid LeukemiaMarch 1st, 2016
  • Epigenetic Pathway and New Drug Show Promise in Reversing a Hard-to-Treat Childhood Cancer
    Epigenetic Pathway and New Drug Show Promise in Reversing a Hard-to-Treat Childhood CancerJuly 11th, 2011
  • American Cancer Society and St. Baldrick’s Foundation Award Additional $720,000 in Research Grants Focused on Advancing Childhood Cancer Treatments
    American Cancer Society and St. Baldrick’s Foundation Award Additional $720,000 in Research Grants Focused on Advancing Childhood Cancer TreatmentsFebruary 17th, 2024

Grant Support

  • H3K79 Methylation In Hematopoietic Stem Cell Development And Mll-Rearranged LeukNational Heart, Lung, And Blood Institute2010–2011

Other Languages

  • Spanish, German

Hospital Affiliations

Dr. Kathrin Bernt, Dr. Kathrin Bernt, MD, Dr. K Bernt, Dr. Kathrin Maria Bernt